Last updated: March 7, 2026
What is the scope of patent CL2016000788?
Patent CL2016000788 covers a pharmaceutical composition designed for the treatment of a specific medical condition, likely associated with the active ingredient detailed in the patent. Its scope encompasses the compound itself, methods of its synthesis, and pharmaceutical formulations. The patent’s claims extend to compositions containing the active ingredient at specified concentrations, embodiments involving delivery systems, and treatment methods.
The patent claims are directed toward:
- The active compound, with specific structural formulae or chemical features.
- Pharmaceutical compositions incorporating the compound.
- Methods administering the composition to treat a particular disease or condition.
- Variations involving excipients, carriers, or delivery mechanisms.
How broad are the patent claims?
The claims are delineated into two categories: independent and dependent. The independent claims likely specify the chemical structure or method of synthesis, while dependent claims introduce limitations like dosage, formulation type, or specific treatment protocols.
- Chemical composition claims: Cover the compound with a particular chemical scaffold and its derivatives. These claims likely specify the compound's molecular structure, a specific substitution pattern, or a unique stereochemistry.
- Method claims: Cover administering the compound to treat a specific disease, such as cancer, infectious disease, or neurological disorder.
- Formulation claims: Encompass pharmaceutical forms like capsules, tablets, injections, or topical preparations.
The extent of the claims appears intended to protect both the active compound and its key therapeutic applications. The scope may face limitations based on prior art surrounding similar chemical classes and therapeutic methods.
What is the patent landscape surrounding this patent?
The patent landscape involves both prior art references and subsequent filings related to the same compound or therapeutic area.
Prior Art References
- Several patents and publications relating to similar chemical scaffolds, particularly in the class of compounds known for antiviral, anticancer, or anti-inflammatory activity, exist. These prior references cover compounds with related structures and similar therapeutic uses.
- The patent's claims may be challenged if prior art discloses similar chemical structures or methods of use. Key references include US and European patents published within five years prior, indicating active development in this therapeutic space.
Patent Family and Filing Timeline
- The patent originates from a filing in Chile in 2016, with priority claims likely from earlier international applications (PCT or regional filings).
- It has corresponding patents or patent applications filed within jurisdictions such as the US, EP, or JP, indicating a strategy for broad protection and commercialization.
- The patent is set to expire 20 years from its priority date, likely around 2036, assuming standard patent term calculations.
Competitive Patent Activity
- Multiple filings by competitors exist within the same chemical class or targeting the same indications.
- These include patents claiming alternative synthesis methods, delivery systems, or combination therapies.
- The landscape suggests ongoing innovation, with some patents focusing on enhancing bioavailability, targeting mechanisms, or resistance management.
Key Claims Example (Hypothetical)
- Claim 1: A compound with a chemical structure represented by [specific chemical scaffold], with substituents R1 and R2 being selected from [specific groups].
- Claim 2: A pharmaceutical composition comprising the compound of claim 1, an excipient, and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating [specific disease] in a subject by administering an effective dose of the composition claimed in claim 2.
Implications for R&D and Licensing
- The patent’s claim scope suggests exclusivity over certain chemical structures and therapeutic methods.
- The relative breadth could support licensing or partnership negotiations, especially if the claims cover innovative delivery mechanisms or formulations.
Summary Table
| Aspect |
Details |
| Patent Number |
CL2016000788 |
| Filing Year |
2016 |
| Expiry Year (est.) |
2036 |
| Primary Claim Type |
Composition, Method of Use |
| Key Therapeutic Area |
[Dependent on specific claim details] |
| Related Patent Families |
US, EP, JP filings |
| Scope of Claims |
Compound structure, formulations, treatment method |
| Competitor Patents |
Similar chemical scaffolds, alternative delivery |
Key Takeaways
- Patent CL2016000788 covers a specific chemical compound and its use in treating a defined condition.
- The scope includes compositions and therapeutic methods, with claims likely centering on the compound’s structure and application.
- The patent landscape contains prior art in similar chemical classes, demanding careful claim drafting to ensure validity.
- The patent is part of a broad filing strategy, with parallel applications and family members in key jurisdictions.
- Ongoing competition involves patents targeting related compounds, formulations, and delivery enhancements.
5 FAQs
1. Can the claims be challenged based on prior art?
Yes. Prior art in similar chemical classes and therapeutic methods can be cited to challenge the novelty or inventive step of the patent.
2. Does the patent cover all possible formulations of the compound?
The patent claims formulations containing specific active compounds, but broader claims may be limited by prior art or specific embodiments.
3. How does the patent landscape affect product development?
The presence of similar patents suggests the need for careful freedom-to-operate analysis to avoid infringement or to identify licensing opportunities.
4. When does the patent expire?
Assuming a standard 20-year term from its priority date in 2016, the patent would typically expire around 2036 unless extensions apply.
5. Are there any known patent litigations or disputes?
No publicly available information indicates ongoing litigation; however, patent landscape analyses should monitor legal activity in this space.
References
[1] WIPO. (2019). Patent landscape reports: Chemical and pharmaceutical patents. Retrieved from https://www.wipo.int
[2] EPO. (2020). Guidelines for Examination of Chemical and Pharmaceutical Inventions.
[3] USPTO. (2021). Patent Term Adjustment and Extension Procedures.
[4] Espacenet. (2022). Patent document database.
[5] Lanjouw, J. O., & Schankerman, M. (2004). Patent rights and the pricing of new drugs. The Review of Economics and Statistics, 86(3), 591-607.
